One year ago this time was World Cup season and Mondial fever put a lot of regional conflicts on the back burner for a month – not to mention put a dent in a lot of family budgets (husbands buying the latest 60 inch Sony Bravia and wives on retail therapy while the guys are …
Read more »One of the biggest challenges in global multi-center clinical trials (after enrollment of patients) is collaboration between multi-center clinical trial teams: CRAs, investigators, regulatory, marketing, manufacturing, market research, data managers, statisticians and site administrators. In a complex global environment, pharma do not have control of computer platforms that local sites use – yet there is …
Read more »In my previous post I attempted to build an argument that “classical” consumer social media like Facebook is not a good fit for a pharmaceutical company due to the way they market innovative drugs.
Read more »If you understand how pharmaceuticals are sold, this is not surprising. What is surprising is that a lot of people seem to think it’s just a question of time before pharmaceutical companies like GSK get into social media. I claim that a fashion trend doesn’t make a business case. The buzz of social media and …
Read more »A year ago, I worked with Joel Isaacson on a VOD / IPTV project - and I’m still pretty interested in whats happening in digital media – especially since we got to say “I told you so”. (we predicted the death of Blu-Ray and the rise of video download two years ago). This note is from …
Read more »This week, I met with one of my former clients who have done some innovative work in the digital media space. They are a typical tech company with typical problems that create typical opportunities for larger companies to buy them out for peanuts. This particular company operates in a difficult and competitive market with long …
Read more »